Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 ,inter alia, to consider and approve Notice of Board Meeting ....
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs & Organics has informed stock exchanges that its Board of Directors will meet on Thursday, August 7, 2025, at the registered office in Mumbai. The main item on the agenda is to consider and approve the Un-Audited Financial Results (both Standalone and Consolidated) for the quarter ended June 30, 2025 (Q1 FY26). The company has already closed its trading window from July 1, 2025 for directors, officers, and designated employees, in line with insider trading regulations. The window will remain closed until 48 hours after the results are officially announced. The filing was signed by Managing Director Govardhan M. Dhoot.
This is a routine pre-results intimation. Shareholders and investors should expect the Q1 FY26 earnings (standalone and consolidated) to be released on or shortly after August 7, 2025, which could move the stock depending on the numbers. The closed trading window means insiders cannot trade until results are out, which is standard compliance.